Clinical efficacy and metabolic impact of two different dosages of ethinyl-estradiol in association with drospirenone in normal-weight women with polycystic ovary syndrome: a randomized study

Daniela Romualdi; Simona De Cicco; M. Busacca; D. Gagliano; Antonio Lanzone; Maurizio Guido

doi:10.1007/BF03346756

Clinical efficacy and metabolic impact of two different dosages of ethinyl-estradiol in association with drospirenone in normal-weight women with polycystic ovary syndrome: a randomized study

Daniela Romualdi
, Simona De Cicco
, M. Busacca
, D. Gagliano
, Antonio Lanzone
, Maurizio Guido

Research output: Contribution to journal › Article

18 Citations (Scopus)

Abstract

The estrogenic component of estro- progestin (EP) is responsible for a negative impact on the metabolic and lipid assessment in women with polycystic ovary syndrome (PCOS).

Original language	English
Pages (from-to)	636-641
Number of pages	6
Journal	Journal of Endocrinological Investigation
Volume	36
DOIs	https://doi.org/10.1007/BF03346756
Publication status	Published - 2013

Keywords

ethynil-estradiol

Access to Document

10.1007/BF03346756

Cite this

Romualdi, D., De Cicco, S., Busacca, M., Gagliano, D., Lanzone, A., & Guido, M. (2013). Clinical efficacy and metabolic impact of two different dosages of ethinyl-estradiol in association with drospirenone in normal-weight women with polycystic ovary syndrome: a randomized study. Journal of Endocrinological Investigation, 36, 636-641. https://doi.org/10.1007/BF03346756

@article{f5f3a6b6eddb49f39c23098c6a46de9c,

title = "Clinical efficacy and metabolic impact of two different dosages of ethinyl-estradiol in association with drospirenone in normal-weight women with polycystic ovary syndrome: a randomized study",

abstract = "The estrogenic component of estro- progestin (EP) is responsible for a negative impact on the metabolic and lipid assessment in women with polycystic ovary syndrome (PCOS).",

keywords = "ethynil-estradiol, ethynil-estradiol",

author = "Daniela Romualdi and \{De Cicco\}, Simona and M. Busacca and D. Gagliano and Antonio Lanzone and Maurizio Guido",

year = "2013",

doi = "10.1007/BF03346756",

language = "English",

volume = "36",

pages = "636--641",

journal = "Journal of Endocrinological Investigation",

issn = "1720-8386",

publisher = "Springer Science and Business Media Deutschland GmbH",

}

Romualdi, D, De Cicco, S, Busacca, M, Gagliano, D, Lanzone, A & Guido, M 2013, 'Clinical efficacy and metabolic impact of two different dosages of ethinyl-estradiol in association with drospirenone in normal-weight women with polycystic ovary syndrome: a randomized study', Journal of Endocrinological Investigation, vol. 36, pp. 636-641. https://doi.org/10.1007/BF03346756

Clinical efficacy and metabolic impact of two different dosages of ethinyl-estradiol in association with drospirenone in normal-weight women with polycystic ovary syndrome: a randomized study. / Romualdi, Daniela; De Cicco, Simona; Busacca, M. et al.
In: Journal of Endocrinological Investigation, Vol. 36, 2013, p. 636-641.

Research output: Contribution to journal › Article

TY - JOUR

T1 - Clinical efficacy and metabolic impact of two different dosages of ethinyl-estradiol in association with drospirenone in normal-weight women with polycystic ovary syndrome: a randomized study

AU - Romualdi, Daniela

AU - De Cicco, Simona

AU - Busacca, M.

AU - Gagliano, D.

AU - Lanzone, Antonio

AU - Guido, Maurizio

PY - 2013

Y1 - 2013

N2 - The estrogenic component of estro- progestin (EP) is responsible for a negative impact on the metabolic and lipid assessment in women with polycystic ovary syndrome (PCOS).

AB - The estrogenic component of estro- progestin (EP) is responsible for a negative impact on the metabolic and lipid assessment in women with polycystic ovary syndrome (PCOS).

KW - ethynil-estradiol

UR - http://hdl.handle.net/10807/53435

U2 - 10.1007/BF03346756

DO - 10.1007/BF03346756

M3 - Article

SN - 1720-8386

VL - 36

SP - 636

EP - 641

JO - Journal of Endocrinological Investigation

JF - Journal of Endocrinological Investigation

ER -

Clinical efficacy and metabolic impact of two different dosages of ethinyl-estradiol in association with drospirenone in normal-weight women with polycystic ovary syndrome: a randomized study

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this